K252851 is an FDA 510(k) clearance for the deepLive (OSP12 + DMS). This device is classified as a System, Imaging, Optical Coherence Tomography (oct) (Class II - Special Controls, product code NQQ).
Submitted by Damae Medical (Paris, FR). The FDA issued a Cleared decision on October 7, 2025, 29 days after receiving the submission on September 8, 2025.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 892.1560. This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging..